Principal Financial Group
MDCO

Principal Financial Group’s Medicines Co MDCO Stock Holding History

Principal Financial Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-606,414
Closed -$51.5M – 2291
2019
Q4 		$51.5M Buy
606,414
+4,762
+0.8% +$318K 0.04% 385
2019
Q3 		$30.1M Buy
601,652
+24,666
+4% +$984K 0.03% 542
2019
Q2 		$21M Buy
576,986
+37,439
+7% +$1.22M 0.02% 727
2019
Q1 		$15.1M Sell
539,547
-4,736
-0.9% -$112K 0.01% 969
2018
Q4 		$10.4M Sell
544,283
-7,140
-1% -$166K 0.01% 1152
2018
Q3 		$16.5M Buy
551,423
+28,310
+5% +$1.07M 0.01% 990
2018
Q2 		$19.2M Buy
523,113
+8,518
+2% +$277K 0.02% 852
2018
Q1 		$16.9M Buy
514,595
+14,611
+3% +$457K 0.02% 899
2017
Q4 		$13.7M Buy
499,984
+7,744
+2% +$239K 0.01% 1071
2017
Q3 		$18.2M Sell
492,240
-68,281
-12% -$2.52M 0.02% 843
2017
Q2 		$21.3M Buy
560,521
+6,388
+1% +$284K 0.02% 734
2017
Q1 		$27.1M Buy
554,133
+32,301
+6% +$1.47M 0.03% 554
2016
Q4 		$17.7M Buy
521,832
+7,146
+1% +$253K 0.02% 773
2016
Q3 		$19.4M Buy
514,686
+15,867
+3% +$598K 0.03% 674
2016
Q2 		$16.8M Buy
498,819
+13,621
+3% +$480K 0.02% 724
2016
Q1 		$15.4M Buy
485,198
+16,341
+3% +$534K 0.02% 728
2015
Q4 		$17.5M Buy
468,857
+36,761
+9% +$1.39M 0.03% 628
2015
Q3 		$16.4M Buy
432,096
+16,661
+4% +$585K 0.03% 635
2015
Q2 		$11.9M Sell
415,435
-2,667
-0.6% -$74.3K 0.02% 885
2015
Q1 		$11.7M Buy
418,102
+9,448
+2% +$265K 0.02% 867
2014
Q4 		$11.3M Buy
408,654
+2,240
+0.6% +$55.5K 0.02% 872
2014
Q3 		$9.07M Sell
406,414
-4,633
-1% -$118K 0.02% 967
2014
Q2 		$11.9M Sell
411,047
-759
-0.2% -$20.3K 0.02% 821
2014
Q1 		$11.7M Sell
411,806
-181,028
-31% -$5.99M 0.02% 810
2013
Q4 		$22.9M Buy
592,834
+32,165
+6% +$1.15M 0.04% 447
2013
Q3 		$18.8M Buy
560,669
+60,303
+12% +$1.92M 0.04% 477
2013
Q2 		$15.4M Buy
+500,366
New +$16.7M 0.03% 538

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Principal Financial Group's MDCO Position: Q1 2020 in Review

Principal Financial Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 606,414 shares — an estimated $51.5M sold.

Principal Financial Group first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $51.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Principal Financial Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Principal Financial Group sold 606,414 Medicines Co shares in Q1 2020, an estimated $51.5M.
  • Principal Financial Group first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Principal Financial Group's Medicines Co position peaked at $51.5M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Principal Financial Group's 13F filing for Q1 2020, filed 12 May 2020.